Medicine & Life Sciences
Lipase
100%
Pancreatitis
71%
Chronic Pancreatitis
65%
Colipases
62%
pancreatic lipase related protein 2
58%
EphA2 Receptor
42%
human PNLIP protein
37%
Acute Myeloid Leukemia
30%
Lymphoma, Large B-Cell, Diffuse
29%
Cell Transplantation
29%
Pediatrics
28%
Allogeneic Cells
25%
plerixafor octahydrochloride
25%
Transplants
21%
Neoplasms
21%
Decitabine
20%
Mantle-Cell Lymphoma
19%
procolipase
19%
Survival
18%
Therapeutics
18%
Hodgkin Disease
18%
Pharmaceutical Preparations
17%
Proteins
17%
Child
17%
Rituximab
17%
Industry
16%
United States Food and Drug Administration
16%
Stem Cell Transplantation
16%
GATA2 Deficiency
15%
Hematopoietic Stem Cell Mobilization
15%
Mutation
15%
Genes
15%
Pancreas
14%
Esters
14%
Drug Approval
14%
Digestion
13%
Natural Killer Cells
13%
Autologous Transplantation
13%
Bile Acids and Salts
13%
Lenalidomide
13%
Drug Therapy
13%
Biological Products
13%
Cytarabine
12%
Granulocyte Colony-Stimulating Factor
12%
Fats
12%
Recurrence
12%
Lymphoma
12%
Tyrosine
12%
Stem Cells
12%
Myelodysplastic Syndromes
12%
Tissue Donors
12%
Progression-Free Survival
12%
T-Lymphocytes
11%
Follicular Lymphoma
11%
Drug Discovery
11%
Dietary Fats
11%
Drug Development
11%
Azacitidine
11%
Cadherins
11%
Bendamustine Hydrochloride
11%
Triglycerides
10%
Growth
10%
Ligands
10%
Confidence Intervals
10%
Biotechnology
10%
Ovarian Neoplasms
10%
Communicable Diseases
9%
Antibodies
9%
Interleukin-15
9%
belinostat
9%
Breast Neoplasms
8%
Messenger RNA
8%
Phosphorylation
8%
Chimeric Antigen Receptors
8%
Integrins
8%
Epithelial Cells
8%
Complementary DNA
8%
Monoclonal Antibodies
8%
Hematopoietic Stem Cell Transplantation
8%
Lipids
7%
Peripheral Blood Stem Cells
7%
Protein-Tyrosine Kinases
7%
Leukemia
7%
Phosphotransferases
7%
Cell Adhesion
7%
Hereditary pancreatitis
7%
Prostatic Intraepithelial Neoplasia
7%
Antiviral Agents
7%
Peripheral T-Cell Lymphoma
7%
etaracizumab
7%
pancreatic lipase-related protein 1
7%
ALT-803
7%
Bone Marrow
6%
PCI 32765
6%
Non-Hodgkin's Lymphoma
6%
National Institute of Diabetes and Digestive and Kidney Diseases (U.S.)
6%
Homologous Transplantation
6%
Pancreatic Neoplasms
6%
Hematopoietic Stem Cells
6%
Micelles
6%
Chemical Compounds
Molecular Entity
45%
Triglyceride
26%
Drug
24%
Protein
19%
Bile Salt
15%
Mutation
11%
Industry
11%
Fat
10%
Biotechnology
9%
Lenalidomide
9%
Pharmaceutical
8%
Refractory
8%
Tyrosine
8%
Orphan Drug
7%
Complementary DNA
7%
Ibrutinib
6%
Chemokine Receptor CXCR4 Antagonist
5%
Disorder
5%
Tributyrin
5%
Antigen
5%
Triolein
5%
Molecule
5%